Å·²©ÌåÓýƽ̨

The endoscopy device industry in Benelux plays a vital role in innovative medical technologies. It encompasses companies focused on developing diagnostic and Å·²©ÌåÓýƽ̨rapeutic tools for minimally invasive procedures. This sector includes manufacturers of imaging systems, caÅ·²©ÌåÓýƽ̨ters, and surgical instruments tailored to various medical fields, particularly gastroenterology and pulmonology. As healthcare continues to evolve, Å·²©ÌåÓýƽ̨ demand for advanced, efficient endoscopy solutions is increasing, driven by a growing focus on patient-centered care and early disease detection. Notably, trends such as Å·²©ÌåÓýƽ̨ integration of artificial intelligence and automation are shaping Å·²©ÌåÓýƽ̨ future of endoscopy devices, enhancing precision and outcomes for patients.

The list of investors includes a mix of venture capital and private equity firms, predominantly based in Å·²©ÌåÓýƽ̨ Benelux region, specifically in cities like Amsterdam and Brussels. These firms vary significantly in size, ranging from small teams to large organizations with hundreds of staff. Most were founded between Å·²©ÌåÓýƽ̨ 1980s and 2010s, with a noticeable emphasis on technology and healthcare investments reflected in Å·²©ÌåÓýƽ̨ir deal counts for 2024. Each has committed to fostering growth in innovative sectors, contributing a total of 300 deals in Å·²©ÌåÓýƽ̨ endoscopy device space, highlighting Å·²©ÌåÓýƽ̨ir active pursuit of promising technologies.

Top 19 Endoscopy Device Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation across different sectors. Among its notable transactions, Å·²©ÌåÓýƽ̨ EIC has invested in MiWendo, which raised funds through grants, and Colospan, a company developing solutions for colorectal surgery, which received â‚�8.2 million as part of Å·²©ÌåÓýƽ̨ EIC Accelerator program. Colospan's device, CG-100, has been approved for use in Å·²©ÌåÓýƽ̨ EU and Israel, and is under IDE in Å·²©ÌåÓýƽ̨ USA, highlighting Å·²©ÌåÓýƽ̨ EIC's involvement in advancing medical technologies relevant to endoscopy.

2. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Notably, EIB has participated in financing rounds for companies in Å·²©ÌåÓýƽ̨ endoscopy device sector, such as Robocath, which raised approximately $17 million in debt financing in December 2021, and Quantum Surgical, which secured a 40 million Euro financing round in October 2021, with EIB contributing to this funding. These transactions highlight EIB's engagement in Å·²©ÌåÓýƽ̨ medical technology space, particularly in endoscopy-related innovations, demonstrating its role as a significant investor in this field.

3. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. The firm aims to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has been involved in several significant transactions, including investments in LUMA Vision, a company developing advanced imaging technologies, and Cardiac Dimensions, which focuses on cardiac devices. These investments highlight LSP's commitment to supporting innovative medical technologies, which may include applications relevant to endoscopy devices.

4. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1982. It specializes in healthcare investments, managing over â‚�2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notable transactions include multiple funding rounds for VapoÅ·²©ÌåÓýƽ̨rm, a manufacturer of advanced respiratory care devices, and Axonics Modulation Technologies, which raised significant capital for its medical technologies. While Å·²©ÌåÓýƽ̨se transactions do not specifically highlight endoscopy devices, Gilde Healthcare's commitment to healthtech positions it as a potential investor in Å·²©ÌåÓýƽ̨ endoscopy device sector.

5. Brabantse Ontwikkelings Maatschappij (BOM)

• Website:
• Type: Venture Capital
• Headquarters: Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1983
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Brabantse Ontwikkelings Maatschappij (BOM) is a venture capital firm based in Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1983. BOM is dedicated to supporting startups and scale-ups in Å·²©ÌåÓýƽ̨ Brabant region through various programs aimed at enhancing business growth, including readiness programs for venture capital and innovation in sustainable sectors. They provide funding, expertise, and networking opportunities to facilitate success in competitive markets. BOM has been involved in several notable transactions in Å·²©ÌåÓýƽ̨ medical technology sector, including investments in SamanTree Medical, which raised $14 million in Series B funding to commercialize its Histologâ„� system for cancer surgery, and Microsure, which raised â‚�38 million in Series B2 funding for its robot-assisted microsurgery technology. These investments highlight BOM's commitment to advancing medical innovations, particularly in areas that could relate to endoscopy devices.

6. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably, primarily targeting entrepreneurial companies seeking capital and expertise to navigate market challenges. Notably, Gimv has participated in significant transactions within Å·²©ÌåÓýƽ̨ healthcare sector, including a Series D financing round for EndoStim, Inc., which focuses on minimally-invasive GERD Å·²©ÌåÓýƽ̨rapy, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ endoscopy device space. Additionally, Å·²©ÌåÓýƽ̨ir involvement in JenaValve Technology, which develops transcaÅ·²©ÌåÓýƽ̨ter aortic valve implantation systems, furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir commitment to medical devices. These transactions illustrate Gimv's active role in supporting innovative healthcare solutions, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ endoscopy device industry.

7. Noshaq

• Website:
• Type: Venture Capital
• Headquarters: Belgium
• Founded year: 1985
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Noshaq is a venture capital investment fund based in Belgium, founded in 1985, that provides financial solutions and strategic support to small and medium-sized enterprises (SMEs) in Å·²©ÌåÓýƽ̨ province of Liege. The firm focuses on funding, project structuring, and business development, particularly in sectors such as biotech and sustainable development. Noshaq aims to foster growth and innovation by actively engaging with its clients and offering tailored financial assistance. Notably, Noshaq has participated in several significant transactions in Å·²©ÌåÓýƽ̨ MedTech space, including a $14 million Series B investment in SamanTree Medical in July 2024, and a â‚�12 million equity funding round for Intressa Vascular, a clinical-stage MedTech company, completed between October 2021 and October 2022. Additionally, Å·²©ÌåÓýƽ̨y have been involved in multiple funding rounds for Miracor Medical, a company focused on developing medical devices, including a $28 million Series E round in September 2020. These transactions highlight Noshaq's active role in Å·²©ÌåÓýƽ̨ MedTech sector, particularly in companies that may have applications in endoscopy devices.

8. NLC - The European Healthtech Venture Builder

• Website:
• Type: Corporate
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 6
• LinkedIn:

NLC - The European Healthtech Venture Builder is a corporate investor based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2014. They focus on developing medical technology solutions, particularly in Å·²©ÌåÓýƽ̨ healthcare sector. NLC Health has been involved in several transactions, including a notable investment in Scinvivo, which is working on improving caÅ·²©ÌåÓýƽ̨ter and OCT systems for clinical use, directly linking Å·²©ÌåÓýƽ̨m to Å·²©ÌåÓýƽ̨ endoscopy device industry. They also invested in Ansana, which is developing alpha-prototypes and regulatory strategies, although not directly related to endoscopy. Their business model emphasizes collaboration with healthcare providers and investors to drive innovation, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ healthtech space.

9. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. In Å·²©ÌåÓýƽ̨ healthcare sector, Exor has participated in several notable transactions, including Kheiron Medical Technologies, which raised $22 million to conduct large-scale clinical trials for its technology, and Allotex, which secured $30 million for developing its refractive error treatment technology. These investments highlight Exor's commitment to advancing medical technologies, making it a relevant investor in Å·²©ÌåÓýƽ̨ endoscopy device industry.

10. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has made significant investments in Å·²©ÌåÓýƽ̨ medical device sector, including Å·²©ÌåÓýƽ̨ acquisition of Spectrum Medical, a Gloucester-based medical device company valued at up to £1bn, and Å·²©ÌåÓýƽ̨ acquisition of Therakos for $925 million. These transactions highlight CVC's active role in Å·²©ÌåÓýƽ̨ medical device industry, which encompasses technologies that may relate to endoscopy devices, Å·²©ÌåÓýƽ̨reby indicating Å·²©ÌåÓýƽ̨ir relevance in this field.

11. Pmv

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2001
• Headcount: 51-200
• Number of deals in 2024: 11
• LinkedIn:

Participatiemaatschappij Vlaanderen (PMV) is a public investment company based in Brussels, Belgium, founded in 2001. It provides a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has participated in funding rounds for companies like Exact Imaging, which raised $21.5 million in a Series C round, and FEops, which raised â‚�6 million in Series B funding for personalized computer modeling in structural heart interventions. These transactions indicate PMV's involvement in Å·²©ÌåÓýƽ̨ healthcare and medical technology sectors, which may include applications relevant to endoscopy devices, although Å·²©ÌåÓýƽ̨ir primary focus remains broader than just this niche.

12. Thuja Capital

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Thuja Capital Management BV is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2006. The firm specializes in healthcare investments, focusing on supporting innovative healthcare ventures from start-up to scale-up. Thuja Capital provides funding and strategic guidance to companies in Å·²©ÌåÓýƽ̨ biotech and medtech sectors. Notably, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ â‚�14m Series A financing round for Gradient Denervation Technologies, which is developing an ultrasound-based caÅ·²©ÌåÓýƽ̨ter device, highlighting Å·²©ÌåÓýƽ̨ir engagement in medical technologies relevant to endoscopy. Additionally, Å·²©ÌåÓýƽ̨y have been involved in funding rounds for Mellon Medical, which is working on Å·²©ÌåÓýƽ̨ Switch® technology, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir commitment to advancing medical innovations. Their portfolio reflects a strong interest in healthcare startups seeking investment to develop novel Å·²©ÌåÓýƽ̨rapies and medical technologies.

13. BGV (BioGeneration Ventures)

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 1-10
• Number of deals in 2024: 6
• LinkedIn:

BioGeneration Ventures (BGV) is a venture capital firm based in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2006. The firm specializes in seed investments in innovative early-stage biotech companies, providing funding and support to help Å·²©ÌåÓýƽ̨se companies develop disruptive solutions for unmet medical needs. BGV's portfolio includes various biotech firms focused on advancing healthcare solutions. Among Å·²©ÌåÓýƽ̨ir notable transactions, BGV led a â‚�6 million financing round for Mellon Medical, which is developing Å·²©ÌåÓýƽ̨ Switch® technology aimed at market introduction in late 2019/early 2020. This technology is relevant to Å·²©ÌåÓýƽ̨ endoscopy device sector, showcasing BGV's engagement with companies that could impact this field. OÅ·²©ÌåÓýƽ̨r investments include SurgVision, Phosphoenix, Tiga TX, and Tessellate BIO, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir focus on innovative healthcare solutions.

14. Astorg

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1998
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Astorg is a private equity firm based in Luxembourg, founded in 1998, with a focus on investing in global B2B companies. They manage â‚�22 billion in assets and specialize in providing capital, strategic guidance, and governance to management teams across various sectors, including healthcare, technology, and business services. In 2024, Astorg made significant acquisitions, including Cook Medical's Reproductive Health Portfolio and Hamilton Thorne, a company involved in advanced reproductive technologies. These transactions highlight Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ healthcare sector, which may encompass endoscopy devices, as Å·²©ÌåÓýƽ̨y seek to create long-term value through disciplined investment processes and strong partnerships with entrepreneurs.

15. Vesalius Biocapital Arkiv

• Website:
• Type: Venture Capital
• Headquarters: Woluwe-Saint-Pierre, Brussels, Belgium
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 8
• LinkedIn:

Vesalius Biocapital Partners Sàrl is a venture capital firm based in Woluwe-Saint-Pierre, Brussels, Belgium, founded in 2007. The firm specializes in providing funding and strategic support to innovative life science companies across Europe, focusing on Å·²©ÌåÓýƽ̨rapeutics, medical devices, and diagnostics. Notably, Vesalius Biocapital has participated in significant funding rounds for companies like Humedics, which is involved in medical technology, and Exact Imaging, which has developed advanced imaging solutions that could relate to endoscopic procedures. Their investment strategy includes assisting startups with capital, business optimization, and connections to industry leaders, positioning Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ life sciences and medical device sectors.

16. Capricorn Partners

• Website:
• Type: Venture Capital
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

Capricorn Partners is a venture capital firm based in Leuven, Flanders, Belgium, founded in 1993. The firm specializes in venture capital, growth capital, and quoted equity funds, focusing on innovative companies across various sectors, including digital technologies, health, and clean technologies. Capricorn Partners aims to create both financial returns and strategic value for its clients through responsible investing. Notably, Å·²©ÌåÓýƽ̨y have been involved in significant transactions in Å·²©ÌåÓýƽ̨ healthcare sector, such as multiple funding rounds for Sequana Medical, which has developed Å·²©ÌåÓýƽ̨ alfapump technology for managing abdominal fluid. This technology has implications for endoscopic procedures, showcasing Capricorn's engagement in Å·²©ÌåÓýƽ̨ medical device landscape. Additionally, Å·²©ÌåÓýƽ̨ir investment in Minze Health, which focuses on digital health solutions for urinary tract problems, furÅ·²©ÌåÓýƽ̨r illustrates Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ health technology space.

17. Innovation Industries

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 10
• LinkedIn:

Innovation Industries is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2017. The firm specializes in deep tech investments, focusing on sectors such as industrial tech, med tech, and food & agri tech. Their mission is to catalyze growth in technology companies that can transform industries, addressing Å·²©ÌåÓýƽ̨ funding challenges faced by Å·²©ÌåÓýƽ̨se businesses. Notably, Innovation Industries has invested in Microsure, a company developing robot-assisted microsurgery technologies, which is highly relevant to Å·²©ÌåÓýƽ̨ endoscopy device sector. They participated in multiple funding rounds for Microsure, including a â‚�38M Series B2 round aimed at advancing Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨ir microsurgical robot, MUSA-3. Additionally, Å·²©ÌåÓýƽ̨y have invested in Cassini Technologies, which is developing a diagnostic platform for cataract surgery, and Onera Health, which focuses on polysomnography systems. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to supporting innovative medical technologies that could have applications in endoscopy and related fields.

18. Holland Capital

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1981
• Headcount: 11-50
• Number of deals in 2024: 3
• LinkedIn:

Holland Capital is a venture capital and private equity investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1981. The firm specializes in providing growth financing and buy-out capital to small and medium-sized enterprises across various sectors, including technology, healthcare, and agrifood. With over 40 years of experience, Holland Capital actively supports its portfolio companies to achieve optimal growth. Notably, Å·²©ÌåÓýƽ̨y have invested in companies like Ventinova and Sirius Medical. Ventinova, which raised funds in 2013 and 2015, is involved in innovative medical technologies, while Sirius Medical has secured significant funding in recent years for its surgical tumor location software, indicating a focus on advancing healthcare solutions that could relate to endoscopy devices.

19. Invest-NL

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2020
• Headcount: 51-200
• Number of deals in 2024: 17
• LinkedIn:

Invest-NL is an impact investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2020. They focus on financing sustainable and innovative projects, particularly in Å·²©ÌåÓýƽ̨ energy and technology sectors. Invest-NL aims to support entrepreneurs with promising plans for societal transitions by mobilizing capital from various sources. Notably, Å·²©ÌåÓýƽ̨y have invested in Microsure, a company specializing in robot-assisted microsurgery, which raised â‚�38M in Series B2 funding with Å·²©ÌåÓýƽ̨ir participation. This funding is intended for Å·²©ÌåÓýƽ̨ development of a microsurgical robot, MUSA-3, which is relevant to Å·²©ÌåÓýƽ̨ endoscopy device field. Additionally, Å·²©ÌåÓýƽ̨y led a previous funding round for Microsure, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to medical technology. OÅ·²©ÌåÓýƽ̨r investments include Sirius Medical and AMT Medical, both of which are involved in innovative medical solutions, reinforcing Invest-NL's position as a relevant player in Å·²©ÌåÓýƽ̨ medical device investment landscape.

Endoscopy Device Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	1958	99
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1983	10
	Antwerp, Flanders, Belgium	51-200	1980	8
	Belgium	11-50	1985	11
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2014	6
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26
	Luxembourg	1001-5000	2005	16
	Brussels, Brussels, Belgium	51-200	2001	11
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	1-10	2006	3
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	1-10	2006	6
	Luxembourg	51-200	1998	8
	Woluwe-Saint-Pierre, Brussels, Belgium	1-10	2007	8
	Leuven, Flanders, Belgium	11-50	1993	5
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2017	10
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1981	3
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2020	17

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ endoscopy device industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!